Welzo, the largest healthcare marketplace in the UK and EU with an impressive user base of over 3.6 million annually, has announced its next expansion plans into the GCC region. This comes ahead of its expected launch into the USA, with interest in the GCC meaning plans in the Middle East have prioritised its US expansion.
The company’s expansion into the GCC marks a significant milestone as the region steps into the future of AI-powered healthcare technology. With the launch of this innovative platform, Welzo will transform healthcare delivery and access across the Gulf Cooperation Council countries.
Welzo has already successfully signed up the largest healthcare suppliers in the GCC, ensuring a robust and comprehensive offering for its users. The company anticipates an initial user base of around 90,000 in the first year, with forecasting pointing towards a substantial increase to 360,000 users by the second year. This rapid growth underscores the significant demand for advanced healthcare solutions in the GCC and positions the region as a leader in AI-driven healthcare innovation.
Welzo MENA Head Office to Be Located in the UAE
The new GCC head offices, strategically located in the UAE, will serve as the central operational hub for Welzo’s activities across the region. With the company set to be operating as Welzo UAE, Welzo Saudi Arabia, Qatar, Kuwait, Oman and Bahrain. This move not only emphasizes Welzo’s commitment to the region but also ensures seamless coordination and delivery of healthcare services and products to a wide array of users.
Local authorities have warmly welcomed Welzo’s expansion, recognising the immense potential it holds for advancing health and wellness technology across the GCC. The integration of AI in healthcare is expected to bring about significant improvements in patient outcomes, healthcare accessibility, and operational efficiency.
Adonis Hakkim, CEO of Welzo, expressed his enthusiasm and confidence about the launch: “We are pleased to bring Welzo to the GCC. Our platform has transformed healthcare access and delivery in the UK and EU, and we are confident it will do the same in the GCC. The integration of AI in healthcare is a game-changer, and we are excited to be at the forefront of this revolution in the region.”
The introduction of Welzo in the GCC is expected to have far-reaching impacts. By providing access to a comprehensive range of healthcare services such as home blood tests and products through an AI-powered platform, Welzo aims to improve patient outcomes and streamline healthcare processes. The platform’s advanced capabilities include personalized health recommendations, real-time monitoring, and predictive analytics, which empower both healthcare providers and patients to make informed decisions.
Local authorities believe that Welzo’s presence will significantly contribute to the GCC’s goal of becoming a global leader in health and wellness technology. The platform’s ability to offer tailored healthcare solutions, facilitate remote consultations, and enhance patient engagement aligns perfectly with the region’s vision for a technologically advanced healthcare ecosystem.
Furthermore, Welzo’s commitment to collaborating with local healthcare providers ensures that the platform is tailored to meet the unique needs of the GCC population. This localised approach not only enhances the relevance and effectiveness of the services offered but also fosters stronger partnerships within the regional healthcare industry.
With its proven track record in the UK and EU, Welzo has set new standards for AI-backed healthcare, ensuring that the GCC remains at the cutting edge of technological advancements in health and wellness. As the largest AI healthcare marketplace in the region, Welzo is dedicated to transforming the way healthcare is delivered and accessed, ultimately contributing to a healthier and more technologically advanced GCC.